Literature DB >> 973980

The administration of drugs and vaccines by the intranasal route.

D S Freestone, A L Weinberg.   

Abstract

Mesh:

Substances:

Year:  1976        PMID: 973980      PMCID: PMC1428945          DOI: 10.1111/j.1365-2125.1976.tb00634.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  27 in total

1.  Viability and infectivity of microorganisms in experimental airborne infection.

Authors:  R J GOODLOW; F A LEONARD
Journal:  Bacteriol Rev       Date:  1961-09

2.  Intranasal use of synthetic oxytocin in management of breast-feeding.

Authors:  P J HUNTINGFORD
Journal:  Br Med J       Date:  1961-03-11

3.  [On the treatment of rhinitis in early childhod; thermoelectric studies on nasal decongestive agents].

Authors:  P BIESALSKI; K MARQUARDT
Journal:  Schweiz Med Wochenschr       Date:  1959-05-09

4.  Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores.

Authors:  H A DRUETT; D W HENDERSON; L PACKMAN; S PEACOCK
Journal:  J Hyg (Lond)       Date:  1953-09

5.  Distribution and removal of human serum albumin-technetium 99m instilled intranasally.

Authors:  F Y Aoki; J C Crowley
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

6.  Short and long term effects on influenza a on lung function.

Authors:  S R Ledder; P W Gill; J K Peat
Journal:  Med J Aust       Date:  1974-11-30       Impact factor: 7.738

7.  A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines.

Authors:  A S Beare; D Hobson; S E Reed; D A Tyrrell
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

8.  Intranasal vaccination with RA 27-3 attenuated rubella virus.

Authors:  R Puschak; M Young; T V McKee; S A Plotkin
Journal:  J Pediatr       Date:  1971-07       Impact factor: 4.406

9.  [Current opinion of nasal therapy from the galenic viewpoint].

Authors:  A Mirimanoff
Journal:  Farmaco Prat       Date:  1969-11

10.  Immunologic and virologic aspects of secretory immune system in human respiratory tract.

Authors:  P L Ogra; A Morag
Journal:  Dev Biol Stand       Date:  1975
View more
  2 in total

1.  Absolute bioavailability of nicotine applied to different nasal regions.

Authors:  C J Johansson; P Olsson; M Bende; T Carlsson; P O Gunnarsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Assessment of the nasal passages.

Authors:  D W Empey
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.